HealthEquity, Inc. (HQY) vs 10x Genomics (TXG)
HealthEquity, Inc. and 10x Genomics are both Health Information Services companies. 10x Genomics is the larger, with a market value of $11.1B against $7.3B — 1.5× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; HealthEquity, Inc. trades at 31.6×. HealthEquity, Inc. grew revenue faster over the last twelve months: 7.34% against −4.28%. HealthEquity, Inc. has the higher net margin (17.4% vs −12.2%) and the higher return on invested capital (8.24% vs −20.2%). Across the 20 metrics below, HealthEquity, Inc. leads on 17 and 10x Genomics on 3.
Valuation
Profitability
| Metric | HQY | TXG | Health Information Services median |
|---|---|---|---|
| Gross margin | 71.25% | 70.03% | 63.38% |
| Operating margin | 25.80% | (14.33%) | (8.35%) |
| Net margin | 17.36% | (12.18%) | (14.70%) |
| Free cash flow margin | 32.08% | 19.68% | 0.58% |
| Return on equity | 11.43% | (9.40%) | (6.82%) |
| Return on assets | 7.07% | (7.47%) | (6.02%) |
| Return on invested capital | 8.24% | (20.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack